Probi and Viva5 announce strategic joint venture to address growing market segments
Swedish based probiotic specialist Probi enters a strategic joint venture with the US based health and wellness company Viva5 Group. The joint venture VivaPro LLC will address the global market in probiotic related business areas. VivaPro will be governed as a standalone company operating out of US. Viva5 Group and Probi will own 51 and 49% share respectively and will have equal representation on the Board of Directors. Probi will have an option to acquire the share majority of the company at a later stage. The joint venture will focus on exploring, researching and co-developing